Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Akebia Therapeutics (AKBA) Ending Cash Balance (2013 - 2026)

Updated

Analysis

Akebia Therapeutics (AKBA) Ending Cash Balance (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn 160.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 160.16 Mn
Jun 30, 2026 157.26 Mn
Mar 31, 2026 164.35 Mn
Dec 31, 2025 186.54 Mn
Sep 30, 2025 168.14 Mn
Jun 30, 2025 139.00 Mn
Mar 31, 2025 115.06 Mn
Dec 31, 2024 53.55 Mn
Sep 30, 2024 35.69 Mn
Jun 30, 2024 41.17 Mn
Mar 31, 2024 43.62 Mn
Dec 31, 2023 44.58 Mn
Sep 30, 2023 48.18 Mn
Jun 30, 2023 55.29 Mn
Mar 31, 2023 59.67 Mn
Dec 31, 2022 93.17 Mn
Sep 30, 2022 147.85 Mn
Jun 30, 2022 146.98 Mn
Mar 31, 2022 177.65 Mn
Dec 31, 2021 151.84 Mn
API Access

Akebia Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=AKBA&period=max&api_key=YOUR_API_KEY